Effect of Propofol Administration Time on the Incidence and Severity of Intrathecal Morphine-induced Pruritus in Parturient Undergoing Elective Cesarean Delivaries
Launched by ASSIUT UNIVERSITY · Dec 3, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how the timing of a medication called propofol affects itching that can occur after receiving morphine during an elective cesarean section (C-section). The researchers want to find out if giving propofol before or after the morphine injection changes how often patients experience itching and how severe it is. This study will help doctors understand better ways to manage this uncomfortable side effect for women undergoing C-sections.
To be eligible for the trial, participants must be women aged 20 to 40 years, in good health (specifically, classified as ASA class I or II), and at least 37 weeks pregnant with a single baby. They must also be scheduled for an elective C-section using a specific type of anesthesia called intrathecal anesthesia. However, women with certain health issues, allergies to the medications being tested, or those who require an emergency C-section will not be able to participate. If you join the study, you can expect to receive either propofol before or after your morphine, and researchers will monitor your experience to gather important information to improve care for future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Parturient of American Society of Anaesthesiologists (ASA) class I or II physical status.
- • Age: 20-40 years.
- • At term gestation (≥ 37 weeks) with a singleton uncomplicated pregnancy.
- • Elective cesarean delivery under intrathecal anaesthesia
- Exclusion Criteria:
- • Parturient refusal.
- • Significant organ dysfunctions (e.g., cardiac, respiratory, renal, or liver disorders).
- • Morbid obesity (BMI \>35).
- • Parturient with known hypersensitivity to propofol, morphine or amide local anaesthetics.
- • Parturient with pruritogenic systemic disease.
- • A coexisting skin disorder or preexisting pregnancy induced pruritus.
- • Parturient with any contraindication for intrathecal anaesthesia, e.g. coagulopathy.
- • Emergency cesarean section.
- • Failed or unsatisfactory intrathecal block.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported